Spinosin

Spinosin is a flavonoid C-glycoside derived from jujube seeds that modulates GABA and serotonin receptors. Studies show it may improve sleep quality and provide neuroprotective effects through neurotransmitter pathway regulation.

Category: Compound Evidence: 2/10 Tier: Preliminary (in-vitro/animal)
Spinosin — Hermetica Encyclopedia

Origin & History

Spinosin is a bioactive flavonoid C-glycoside isolated primarily from the seeds of Ziziphus jujuba var. spinosa (known as Ziziphi Spinosae Semen or Suanzaoren in traditional Chinese medicine). It is extracted through methods including decoction, ethanol extraction, or advanced techniques like UHPLC-Q-Exactive-MS/MS for quality control.

Historical & Cultural Context

Spinosin is a key component of Semen Ziziphi Spinosae, used in Traditional Chinese Medicine for millennia to treat insomnia, anxiety, and neurological disorders. It has been historically applied as a sedative and sleep aid, typically prepared in decoction form.

Health Benefits

• Sleep improvement: Preclinical rat studies showed improved sleep latency and duration through modulation of serotonin and GABA receptors (animal evidence only)
• Neuroprotective effects: Demonstrates cognitive improvement potential in pharmacological reviews (limited preclinical data)
• Sedative properties: Shows sedative actions via neurological pathway modulation (preclinical evidence)
• Anxiolytic effects: Exhibits anxiety-reducing properties in pharmacological assessments (preclinical studies)
• Hypothalamic function: Restores histopathological changes in hypothalamus in animal models (rat study evidence)

How It Works

Spinosin enhances GABAergic neurotransmission by binding to GABA-A receptors, promoting sedative and anxiolytic effects. It also modulates serotonin pathways, particularly 5-HT1A and 5-HT2A receptors, which regulate sleep-wake cycles. Additionally, spinosin demonstrates neuroprotective activity through antioxidant mechanisms and inhibition of acetylcholinesterase enzyme.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on spinosin were identified in the available evidence. Current research is limited to preclinical pharmacology and animal models, including one rat study using a PCPA-induced insomnia model that showed improvements in sleep parameters through hypothalamic gene expression modulation.

Clinical Summary

Current evidence for spinosin is limited to preclinical animal studies, with no human clinical trials available. Rat studies demonstrate improved sleep latency and duration at doses of 5-20 mg/kg body weight. Pharmacological reviews suggest potential cognitive benefits, but these findings require human validation. The lack of human clinical data significantly limits evidence strength for therapeutic applications.

Nutritional Profile

Spinosin is a C-glycoside flavonoid (chemical formula: C28H32O15, molecular weight: 608.55 g/mol) isolated primarily from the seeds of Ziziphus jujuba var. spinosa (Suan Zao Ren). It is not a nutritional macronutrient source but rather a specialized bioactive phytochemical. Key characteristics: • Classification: 2''-O-β-glucopyranosyl-swertisin; a flavone C-glycoside with apigenin as the aglycone backbone, substituted with glucose moieties at the C-6 position and an additional glucose unit at the 2''-hydroxyl. • Typical concentration in source material: Approximately 0.02–0.15% (w/w) in dried Ziziphus jujuba seeds, varying by cultivar, harvest time, and extraction method. Standardized extracts of Suan Zao Ren may contain 1–5% spinosin. • Co-occurring bioactive compounds in the plant matrix: jujuboside A and B (triterpenoid saponins), 6'''-feruloylspinosin, flavonoids (swertish, isospinosin), alkaloids (sanjoinine A), and fatty acids (linoleic acid, oleic acid). • Bioavailability notes: As a C-glycoside flavonoid, spinosin demonstrates relatively higher metabolic stability compared to O-glycosides because the C-C bond linking the sugar to the aglycone is resistant to hydrolysis by intestinal β-glucosidases. Oral bioavailability in rodent models is estimated to be low-to-moderate (exact human bioavailability data are lacking). Gut microbiota may play a role in partial metabolism. The compound crosses the blood-brain barrier in preclinical models, which is consistent with its observed central nervous system effects. • Solubility: Moderately soluble in water and aqueous ethanol solutions; poor solubility in non-polar organic solvents. • No significant macronutrient (protein, fat, carbohydrate, fiber), vitamin, or mineral content is attributable to spinosin itself, as it is consumed in microgram-to-milligram quantities as part of herbal preparations rather than as a food source.

Preparation & Dosage

No clinically studied dosage ranges for spinosin in humans are available. In animal studies, spinosin was administered as part of Ziziphi Spinosae Semen extract, but specific dosages, forms, or standardization levels were not quantified. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

GABA, L-theanine, Magnesium, Valerian root, Passionflower

Safety & Interactions

Safety data for spinosin is extremely limited due to lack of human studies. Potential side effects may include excessive sedation, drowsiness, or interactions with GABAergic medications like benzodiazepines. Individuals taking sleep medications, antidepressants, or anxiolytics should exercise caution due to possible additive effects. Pregnancy and breastfeeding safety is unknown and should be avoided.